Furthermore, MASH patients exhibited significantly higher BMI, ALT, AST, UA, TG, FPG, HbA1c, EO%, and Tf levels compared to borderline cases (all P < 0.05). The gene discussed is TF; the disease is metabolic dysfunction-associated steatohepatitis.